KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-cash Items (2016 - 2025)

Rigel Pharmaceuticals has reported Non-cash Items over the past 14 years, most recently at $3.2 million for Q3 2025.

  • For Q3 2025, Non-cash Items fell 73.33% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, down 73.33%, while the annual FY2024 figure was $2.7 million, 74.97% down from the prior year.
  • Non-cash Items for Q3 2025 was $3.2 million at Rigel Pharmaceuticals, roughly flat from $3.2 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $19.4 million in Q1 2022 and troughed at $1.6 million in Q4 2022.
  • A 5-year average of $8.1 million and a median of $5.3 million in 2023 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: soared 560.44% in 2023 and later plummeted 84.85% in 2024.
  • Year by year, Non-cash Items stood at $6.8 million in 2021, then plummeted by 76.44% to $1.6 million in 2022, then soared by 560.44% to $10.6 million in 2023, then plummeted by 74.97% to $2.7 million in 2024, then increased by 20.62% to $3.2 million in 2025.
  • Business Quant data shows Non-cash Items for RIGL at $3.2 million in Q3 2025, $3.2 million in Q2 2025, and $3.5 million in Q1 2025.